NEW

FDA Releases Two Companion Reports on Medical Device Safety and Innovation

Today, the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health Center (CDRH) is releasing two reports on medical device safety and innovation – the core pillars that help protect and promote public health for all. The “CDRH 2024 Safety...

Tri-Imaging, RTI Group Work Together

In a LinkedIn post, Tri-Imaging states, “We are honored to be the first ISO in North America to have the opportunity to try RTI’s new Mako X-Ray Testing Meter. The Mako meter is the most accurate and efficient testing meter that covers the broadest application range...

Detection Technology announces global availability of TFT flat panel detectors

Detection Technology, a global leader in X-ray detector solutions, announces the global availability of a comprehensive range of TFT (thin-film transistor) flat panel detectors. The portfolio includes IGZO (indium gallium zinc oxide) and a-Si (amorphous silicon)...

Bayer, Google Cloud Accelerate Development of AI-Powered Applications for Imaging

Bayer and Google Cloud have announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will further develop its innovation platform to...

Toshiba Medical Aquilion ONE/GENESIS Edition

The Aquilion ONE/GENESIS Edition maximizes the patient experience during CT examinations, and through intelligent examination protocols, provides excellent image quality with low radiation and contrast dose tailored to each and every patient. The system features an optimized beam spectrum based on PUREViSION Optics, PUREViSION CT Detector and FIRST (MBIR), improving high-contrast spatial resolution up to 129 percent (2.29 times), while reducing radiation dose up to 82.4 percent. With AIDR 3D reconstruction times up to 80 images per second and FIRST reconstruction, exams are fast and safe for patients.

 

View the Product Spotlight

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

Open